Ernexa Therapeutics Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Ernexa Therapeutics Inc. (ERNA), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are ERNA insiders buying or selling?
Ernexa Therapeutics Inc. insiders reported 24 open-market buys ($7.7M) and 10 sells ($9.6M) across 34 Form 4 filings — a net selling position of $1.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 18, 2026)
Insider sentiment
Net sellingNet insider flow of $1.9M in net selling.
Recent ERNA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Cherington Charles | 10% Owner | Purchase | 4.0M | $0.50 | $2.0M |
| Jun 12, 2025 | Cherington Charles | 10% Owner | Purchase | 21.2M | $0.10 | $2.2M |
| May 7, 2025 | Cherington Charles | 10% Owner | Purchase | 13.3M | $0.00 | $0 |
| Apr 4, 2025 | Cherington Charles | 10% Owner | Purchase | 3.8M | $0.10 | $394.2K |
| Nov 5, 2024 | Cherington Charles | 10% Owner | Purchase | 13.3M | $0.00 | $0 |
| Dec 7, 2022 | Cherington Charles | Director, 10% Owner | Purchase | 261.8K | $3.28 | $858.6K |
| Dec 6, 2022 | Singer Nicholas Jason | Director | Purchase | 283.3K | $3.28 | $929.2K |
| Dec 5, 2022 | HALPERN JOHN D | 10% Owner | Purchase | 335.9K | $3.28 | $1.1M |
| Aug 20, 2021 | DENNY GEORGE P III | 10% Owner | Sale | 75.0K | $16.06 | $1.2M |
| Jun 21, 2021 | Cherington Charles | Director, 10% Owner | Sale | 400.0K | $15.74 | $6.3M |
| Aug 17, 2020 | Robert S Ellin | 10% Owner | Sale | 327.6K | $5.55 | $1.8M |
| Jun 19, 2020 | Robert S Ellin | 10% Owner | Sale | 12.5K | $5.99 | $74.9K |
| Jun 4, 2020 | Jeffrey Alan Berg | 10% Owner | Sale | 21.9K | $1.10 | $24.1K |
| Jun 3, 2020 | Jeffrey Alan Berg | 10% Owner | Sale | 60.7K | $1.02 | $62.2K |
| Jun 1, 2020 | Jeffrey Alan Berg | 10% Owner | Sale | 37.3K | $1.07 | $39.8K |
| May 29, 2020 | Jeffrey Alan Berg | 10% Owner | Sale | 25.0K | $1.09 | $27.3K |
| Dec 28, 2019 | Robert S Ellin | 10% Owner | Purchase | 400 | $2.82 | $1.1K |
| Dec 26, 2019 | Jeffrey Alan Berg | 10% Owner | Sale | 1.9K | $2.69 | $5.1K |
| Dec 21, 2019 | Robert S Ellin | 10% Owner | Purchase | 299 | $2.72 | $814.3 |
| Dec 6, 2019 | Robert S Ellin | 10% Owner | Purchase | 100 | $2.90 | $290 |
| Dec 5, 2019 | Robert S Ellin | 10% Owner | Purchase | 100 | $3.50 | $350 |
| Oct 31, 2019 | Robert S Ellin | 10% Owner | Purchase | 881 | $3.15 | $2.8K |
| Oct 29, 2019 | Robert S Ellin | 10% Owner | Purchase | 302 | $3.09 | $934.03 |
| Oct 25, 2019 | Robert S Ellin | 10% Owner | Purchase | 4.8K | $2.78 | $13.3K |
| Oct 17, 2019 | Robert S Ellin | 10% Owner | Purchase | 300 | $3.66 | $1.1K |
Showing the 25 most recent of 34 Form 4 filings for Ernexa Therapeutics Inc..
Most active ERNA insiders
- Robert S Ellin19 filings
- Cherington Charles7 filings
- Jeffrey Alan Berg5 filings
- DENNY GEORGE P III1 filing
- HALPERN JOHN D1 filing
Ask anything about ERNA insider activity
Use Trabud's AI agent to query Ernexa Therapeutics Inc.'s Form 4 history in plain English — "Show me ERNA CEO purchases this year" or compare it against any other ticker.
Open the AI agentERNA insider trading FAQ
Are Ernexa Therapeutics Inc. insiders buying or selling?
Across 34 SEC Form 4 filings, Ernexa Therapeutics Inc. (ERNA) insiders reported 24 open-market purchases totaling $7.7M and 10 sales totaling $9.6M. That is a net selling position of $1.9M.
How many insiders trade ERNA stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Ernexa Therapeutics Inc.. The most recent filing was accepted on Feb 18, 2026.
Where does Trabud get ERNA insider trading data?
All ERNA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.